Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant PalloV-CC Vaccine in Colon Cancer
NCT03827967Phase 1Completed
- Start
- Jul 2019
- Primary completion
- Apr 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label trial of PalloV-CC in colon cancer (4 arms). Primary endpoints: Overall number of participants with treatment-related adverse events at 1 year and Overall Immunoscore of the tumor microenvironment at 1 year. Started Jul 2019; status: completed.
02
Drugs
PalloV-CC
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT03827967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03827967.